Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial (Q46418787)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial |
scientific article |
Statements
1 reference
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial (English)
1 reference
Victor F Tapson
1 reference
Zhi-Cheng Jing
1 reference
Kai-Feng Xu
1 reference
Lei Pan
1 reference
Jeremy Feldman
1 reference
David G Kiely
1 reference
Eugene Kotlyar
1 reference
C Shane McSwain
1 reference
Kevin Laliberte
1 reference
Carl Arneson
1 reference
Lewis J Rubin
1 reference
FREEDOM-C2 Study Team
1 reference
1 September 2013
1 reference
1 reference
144
1 reference
3
1 reference
952-958
1 reference
Identifiers
1 reference
1 reference